Skip to main content
Log in

Mortality in relation to presence and type of oral antithrombotic agent among adult trauma patients: a single-center retrospective cohort study

  • Original Article
  • Published:
European Journal of Trauma and Emergency Surgery Aims and scope Submit manuscript

Abstract

Purpose

Oral anticoagulants (AC) and antiplatelet (AP) agents are increasingly prescribed to prevent and treat acute and chronic thrombotic conditions. The direct oral anticoagulants (DOAC), a newer class of AC, raise concerns in the trauma setting. Our study aims to compare the mortality rates and other outcomes among adult trauma patients based on pre-admission AC/AP status.

Methods

We conducted a retrospective cohort study of a prospectively collected database of trauma patients previously on DOAC, warfarin, aspirin or clopidogrel. A matched control group of trauma patients not receiving AC/AP was used for comparison. Our primary endpoint was in-hospital mortality according to antithrombotic medication class. Secondary endpoints included length of stay (LOS), intensive care unit (ICU) admission, need for blood transfusion, and discharge to a dependent setting. Univariate and multivariate analyses were conducted.

Results

There were 996 exposed patients and 234 controls, with no major clinically significant difference among study groups in terms of gender, injury site, injury severity, mechanism, and comorbidities. The mortality rates were 2.14% (control, 5/234), 2.88% (DOAC, 3/104), 3.34% (aspirin, 17/509), 7.63% (warfarin, 18/236), 9% (clopidogrel, 8/89), and 13.79% (aspirin + clopidogrel, 8/58) (p < 0.001). In multivariate analyses, there was no difference regarding mortality between DOAC and reference groups. Blood transfusion was more likely in patients receiving warfarin or AP than those prescribed DOAC.

Conclusion

There was no evidence of increased mortality or blood transfusion requirement among trauma patients on DOAC, including head trauma patients. Further studies on head trauma and specific subgroups of DOAC are recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Maung AA, Bhattacharya B, Schuster KM, Davis KA. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg. 2016;81:652–7. https://doi.org/10.1097/TA.0000000000001189.

    Article  CAS  PubMed  Google Scholar 

  2. Dezman ZD, Comer AC, Smith GS, Narayan M, Hess JR, Hirshon JM. The severity of bleeding and mortality in trauma patients taking Dabigatran. J Emerg Med. 2016;51:238–45. https://doi.org/10.1016/j.jemermed.2016.05.005.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fohtung RB, Novak E, Rich MW. Effect of new oral anticoagulants on prescribing practices for atrial fibrillation in older adults. J Am Geriatr Soc. 2017;65:2405–12. https://doi.org/10.1111/jgs.15058.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Vranckx P, Valgimigli M, Heidbuchel H. The significance of drug–drug and drug–food interactions of oral anticoagulation. Arrhythm Electrophysiol Rev. 2018;7:55–61. https://doi.org/10.15420/aer.2017.50.1.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967–77. https://doi.org/10.2147/TCRM.S84210.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wood B, Nascimento B, Rizoli S, Sholzberg M, McFarlan A, Phillips A, et al. The anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective. Scand J Trauma Resusc Emerg Med. 2017;25:76. https://doi.org/10.1186/s13049-017-0420-y.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Egea-Guerrero JJ, Quintana DM. New oral anticoagulants in severe trauma patients: enemy at the gates? Med Intensiva. 2015;39:167–71. https://doi.org/10.1016/j.medin.2014.09.008.

    Article  CAS  PubMed  Google Scholar 

  8. Feeney JM, Neulander M, DiFiori M, Kis L, Shapiro DS, Jayaraman V, et al. Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma. Injury. 2017;48:47–50. https://doi.org/10.1016/j.injury.2016.08.016.

    Article  PubMed  Google Scholar 

  9. LaDuke ZJ, Hecht JP, Cain-Nielsen AH, Hemmila MR, Wahl WL. Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists. Surgery. 2019;166:564–71. https://doi.org/10.1016/j.surg.2019.04.039.

    Article  PubMed  Google Scholar 

  10. Barben J, Menu D, Rosay C, Vovelle J, Mihai AM, Nuss V, et al. The prescription of direct oral anticoagulants in the elderly: an observational study of 19798 ambulatory subjects. Int J Clin Pract. 2019;2019:13420. https://doi.org/10.1111/ijcp.13420.

    Article  Google Scholar 

  11. Kobayashi L, Barmparas G, Bosarge P, Brown CV, Bukur M, Carrick MM, et al. Novel oral anticoagulants and trauma: The results of a prospective American association for the surgery of trauma multi-institutional trial. J Trauma Acute Care Surg. 2017;82:827–35. https://doi.org/10.1097/TA.0000000000001414.

    Article  CAS  PubMed  Google Scholar 

  12. Barletta JF, Hall S, Sucher JF, Dzandu JK, Haley M, Mangram AJ. The impact of pre-injury direct oral anticoagulants compared to warfarin in geriatric G-60 trauma patients. Eur J Trauma Emerg Surg. 2017;43:445–9. https://doi.org/10.1007/s00068-017-0772-z.

    Article  CAS  PubMed  Google Scholar 

  13. Campbell AJ, Spears GF, Borrie MJ. Examination by logistic regression modelling of the variables which increase the relative risk of elderly women falling compared to elderly men. J Clin Epidemiol. 1990;43:1415–20. https://doi.org/10.1016/0895-4356(90)90110-b.

    Article  CAS  PubMed  Google Scholar 

  14. Zeeshan M, Jehan F, O'Keeffe T, Khan M, Zakaria ER, Hamidi M, et al. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI. J Trauma Acute Care Surg. 2018;85:915–20. https://doi.org/10.1097/TA.0000000000001995.

    Article  CAS  PubMed  Google Scholar 

  15. Dager WE, Banares L. Reversing the anticoagulation effects of dabigatran. Hosp Pract. 2017;45:29–38. https://doi.org/10.1080/21548331.2017.1298389.

    Article  Google Scholar 

  16. Plitt A, Bansilal S. The nonvitamin K antagonist oral anticoagulants and atrial fibrillation: challenges and considerations. J Atr Fibrillation. 2017;9:1547. https://doi.org/10.4022/jafib.1547.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mavrakanas TA, Samer C, Fontana P, Perrier A. Direct oral anticoagulants: efficacy and safety in patient subgroups. Swiss Med Wkly. 2015;145:w14081. https://doi.org/10.4414/smw.2015.14081.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study formed part of a master’s thesis of Karry J Felix at the Braun School of Public Health and Community Medicine, Hadassah-Hebrew University. Ellen Sieh provided English language copy editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miklosh Bala.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file 1 (DOCX 15 kb)

Supplementary file 2 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuval, J.B., Felix, K.J., Demma, J. et al. Mortality in relation to presence and type of oral antithrombotic agent among adult trauma patients: a single-center retrospective cohort study. Eur J Trauma Emerg Surg 48, 497–505 (2022). https://doi.org/10.1007/s00068-020-01429-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00068-020-01429-7

Keywords

Navigation